Biotech

Biotie Advances Clinical Program for SYN120 With Imaging Study at Johns Hopkins Center of Excellence

TURKU, FINLAND: TURKU, FINLAND -- (Marketwire) -- 07/25/11 -- Biotie today announced the start of a Phase 1 clinical study using positron emission tomography (PET) imaging to investigate brain concentrations of SYN1 ...

iCo Therapeutics Announces Resignation of John Clement, Chief Technology and Development Officer and Director

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 07/22/11 -- iCo Therapeutics Inc. (TSX VENTURE: ICO) today announced that John Clement, a co-founder of iCo Therapeutics Inc., has resigned from his po ...

Long-Term Positives En-Route, Review of Healthcare Reform - Equity Research on Achillion Pharmaceuticals, Inc. and Health Management Associates, Inc.

HONG KONG: HONG KONG -- (Marketwire) -- 07/22/11 -- Today, released its industry report highlighting Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) and Health Management Associates, Inc. (NYSE: HMA). Full fun ...

Dynavax Phase 3 Demonstrates Superiority and Safety of HEPLISAV(TM) vs. Engerix-B(R)

BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 07/20/11 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today said that top-line data from its Phase 3 trial comparing HEPLISAV, an investigational hepatitis B vir ...

Agennix Hires Christine Boisclair as Senior Vice President of Global Regulatory Affairs

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX -- (Marketwire) -- 07/20/11 -- Agennix AG (FRANKFURT: AGX) today announced the appointment of Christine Boisclair as Senior Vic ...

iCo Therapeutics Engages The Equicom Group

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 07/19/11 -- iCo Therapeutics Inc. (TSX VENTURE: ICO) today announced that it has retained The Equicom Group Inc. ("Equicom") to provide iCo w ...

P2D Bioscience Receives NIH Funding to Develop Drugs for Lung Disease

CINCINNATI, OH and MUMBAI, INDIA: CINCINNATI, OH and MUMBAI, INDIA -- (Marketwire) -- 07/19/11 -- (P2D, Inc.), a pharmaceutical development company, announced today that the company has received a $320,000 grant from the U.S. Natio ...

PharmaGap Completes Arrangements for Bladder Cancer Test Program

OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwire) -- 07/19/11 -- PharmaGap Inc. (TSX VENTURE: GAP)(OTCBB: PHRGF)("PharmaGap" or "the Company") today announced that it has completed contractual arr ...

Cellceutix Receives Notice of Acceptance for Phase 1 Clinical Trial

BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 07/19/11 -- Cellceutix Corporation (OTCQB: CTIX) (PINKSHEETS: CTIX), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat un ...

Stem Cell Therapeutics Corp. Announces Dr. Calvin R. Stiller and Dr Niclas Stiernholm to Join Board of Directors

CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwire) -- 07/18/11 -- Stem Cell Therapeutics Corp. (TSX VENTURE: SSS) today announced the appointment of Dr. Calvin Stiller and Dr. Niclas Stiernholm to the company's ...